Compare Global X Robotics and Artificial Intelligence ETF (BOTZ) vs Centene Corp (CNC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X Robotics and Artificial Intelligence ETF vs Centene Corp — how do they compare? Global X Robotics and Artificial Intelligence ETF trades at $36.2, while Centene Corp trades at $68.55 (market cap $33.72B). The key difference: Centene Corp is trading nearer its 52-week high, Global X Robotics and Artificial Intelligence ETF nearer its low. Which is the better fit depends on your goals.
| BOTZ | CNC | |
|---|---|---|
52-Week High | $41.63 | $68.72 |
52-Week Low | $31.99 | $25.21 |
Market Cap | — | $33.72B |
Sector | — | Health |
Enterprise Value | — | $26.35B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BOTZ (Global X Robotics & Artificial Intelligence ETF) trades at $35.87, down 2.82% with a bearish technical signal. The ETF faces selling pressure as moving averages indicate a downtrend, though oversold RSI levels suggest potential near-term stabilization. Recent news highlights robotics and AI as emerging investment themes, with China's EV targets and humanoid robotics developments creating sector tailwinds.
The robotics/AI thematic ETF offers exposure to automation growth but lacks traditional valuation metrics. Key risks include sector concentration and technology disruption volatility. Analyst sentiment remains cautiously optimistic on long-term automation trends, though current technical weakness requires monitoring for entry points in this rapidly evolving sector.
Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.
Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Global X Robotics and Artificial Intelligence ETF
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that are involved in the development of robotics and/or artificial intelligence. The fund is non-diversified.
Read more on BOTZ →About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →
